Skip to main content
. 2017 Mar 22;8(44):75864–75873. doi: 10.18632/oncotarget.16439

Figure 2. Percentage of doxorubicin and epirubicin in adjuvant chemotherapy regimens containing anthracyclines from 1999 to 2008.

Figure 2